D0590 | 1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazinane-2,4,6-trione
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 12.20±2.84 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 44.67 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 26.79±25.28 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Warning |
Aggregated GHS information provided by 364 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. Reported as not meeting GHS hazard criteria by 106 of 364 companies. For more detailed information, please visit ECHA C&L website Of the 4 notification(s) provided by 258 of 364 companies with hazard statement code(s): H315 (15.12%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (15.12%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (14.73%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure Respiratory tract irritation] H413 (84.5%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P261, P264, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 1,3,5-Tis(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H, 3H, 5H)- trione | 1,3,5-Tri(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione | 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris((4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl)methyl)- |
| 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris[[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]methyl]- | 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione,1,3,5-tris[[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]methyl]- | 1,3,5-Tris((4-tert-butyl-3-hydroxy-2,6-xylyl)methyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione |
| 1,3,5-Tris(4-(tert-butyl)-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazinane-2,4,6-trione | 1,3,5-Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione;Irganox 1790 | 1,3,5-tris(4-t-butyl-3-hydroxy-2,6-dimethyl-benzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)trione |
| 1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) 1,3,5-triazine-2,4,6-(1h,3h,5h)-trione | 1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazinane-2,4,6-trione | 1,3,5-tris(4-tert.-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1h,3h,5h)-trione; |
| 1,3,5-tris-(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)-s-triazine-2,4,6-(1h,3h,5h)-trione | 253H13NWCQ | 40601-76-1 |
| AK676329 | AKOS025310998 | AO 1790 |
| Antioxidant 1790 | BIDD:ER0469 | C42H57N3O6 |
| CAS-40601-76-1 | CHEMBL3184256 | CTK4I3412 |
| CY 1790 | Cyanox 1790 | Cyanox CY 1790 |
| DN 90 | DS-3342 | DSSTox_CID_8008 |
| DSSTox_GSID_28008 | DSSTox_RID_78637 | DTXSID8028008 |
| EC 254-996-9 | EINECS 254-996-9 | FT-0698392 |
| Irganox 3790 | Isocyanuric Acid Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) Ester | KS-00000JDH |
| LS-179630 | Lowinox 1790 | NCGC00248836-01 |
| NCGC00258351-01 | O819 | Q27253902 |
| SCHEMBL26717 | Tox21_200797 | Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate |
| Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate, 97% | UNII-253H13NWCQ | XYXJKPCGSGVSBO-UHFFFAOYSA-N |
| ZINC95803284 | tris(4-tert-butyl-3-hydroxy-2,6-dimethyl-benzyl) |
| CAS Number | 40601-76-1, 42953-11-7 |
| PubChem Compound | 93221 |